ArticleFrontiers in oncology2025

Efficacy and safety of TACE-HAIC combined with tyrosine kinase inhibitors and immune checkpoint inhibitors for the patients with BCLC-defined stage B-C HCC.

Bowen Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.